SG Americas Securities, LLC - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 187 filers reported holding NEVRO CORP in Q1 2020. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2023$274
+66.1%
14,256
+243.1%
0.00%
+50.0%
Q4 2022$165
-100.0%
4,155
-53.2%
0.00%
-60.0%
Q3 2022$414,000
+162.0%
8,884
+147.1%
0.01%
+150.0%
Q2 2022$158,000
-91.9%
3,595
-86.7%
0.00%
-85.7%
Q1 2022$1,948,000
-25.8%
26,934
-16.9%
0.01%0.0%
Q4 2021$2,627,000
+41.3%
32,409
+102.9%
0.01%
+55.6%
Q3 2021$1,859,000
+0.9%
15,973
+43.7%
0.01%0.0%
Q2 2021$1,843,000
+78.1%
11,118
+49.9%
0.01%
+80.0%
Q1 2021$1,035,000
+18.8%
7,416
+47.3%
0.01%0.0%
Q4 2020$871,000
-43.5%
5,033
-54.5%
0.01%
-50.0%
Q3 2020$1,542,000
+12.2%
11,071
-3.7%
0.01%
-9.1%
Q2 2020$1,374,000
-26.0%
11,502
-38.1%
0.01%
-35.3%
Q1 2020$1,858,000
+898.9%
18,582
+1074.6%
0.02%
+750.0%
Q4 2019$186,000
-68.9%
1,582
-77.3%
0.00%
-60.0%
Q3 2019$599,000
-69.6%
6,963
-77.1%
0.01%
-64.3%
Q2 2019$1,971,000
+268.4%
30,398
+255.3%
0.01%
+180.0%
Q1 2019$535,000
-72.6%
8,556
-82.9%
0.01%
-70.6%
Q4 2018$1,951,000
+1264.3%
50,165
+2699.4%
0.02%
+1600.0%
Q2 2018$143,000
-31.2%
1,792
-25.3%
0.00%
-50.0%
Q1 2018$208,000
+96.2%
2,400
+68.2%
0.00%
+100.0%
Q2 2017$106,000
-48.8%
1,427
-35.5%
0.00%
-50.0%
Q1 2017$207,000
+71.1%
2,214
+32.4%
0.00%
+100.0%
Q4 2016$121,000
-49.4%
1,672
-27.0%
0.00%
-66.7%
Q3 2016$239,0002,2910.00%
Other shareholders
NEVRO CORP shareholders Q1 2020
NameSharesValueWeighting ↓
BRAIDWELL LP 1,192,298$47,215,0011.58%
Altium Capital Management LP 76,000$3,009,6001.53%
Rock Springs Capital Management LP 1,077,900$42,684,8401.03%
Integral Health Asset Management, LLC 109,000$4,316,4000.91%
ArrowMark Colorado Holdings LLC 1,252,218$49,587,8330.59%
FOX RUN MANAGEMENT, L.L.C. 26,963$1,067,7350.43%
PDT Partners, LLC 55,715$2,206,3140.36%
FRED ALGER MANAGEMENT, LLC 1,184,000$46,886,4000.25%
Dynamic Technology Lab Private Ltd 62,819$2,4880.25%
K2 PRINCIPAL FUND, L.P. 38,000$1,504,8000.23%
View complete list of NEVRO CORP shareholders